NG Tessarollo, ACM Domingues, F Antunes, JCS Luz… - Cancers, 2021 - mdpi.com
Simple Summary The treatment of cancer has progressed greatly with the advent of immunotherapy and gene therapy, including the use of nonreplicating adenoviral vectors to …
Y Kim, D Lee, J Lee, S Lee, S Lawler - PloS one, 2019 - journals.plos.org
Neutrophils display rapid and potent innate immune responses in various diseases. Tumor- associated neutrophils (TANs) however either induce or overcome immunosuppressive …
AA de Los Reyes, Y Kim - Royal Society open science, 2022 - royalsocietypublishing.org
In a tumour microenvironment, tumour-associated neutrophils could display two opposing differential phenotypes: anti-tumour (N1) and pro-tumour (N2) effector cells. Converting N2 …
Malignant melanoma is a type of cancer with high death rates due, in part, to the lack of efficient treatments once metastases have formed. 1 The tumor suppressor protein p53 is …
J Lee, D Lee, Y Kim - Royal Society open science, 2021 - royalsocietypublishing.org
In various diseases, the STAT family display various cellular controls over various challenges faced by the immune system and cell death programs. In this study, we …
Y Bao, C Tong, X Xiong - Life Sciences, 2024 - Elsevier
Abstract CXCL3 (CXC Motif Chemokine 3), a member of the CXC chemokine subfamily, operates as a potent chemoattractant for neutrophils, thereby orchestrating the recruitment …
Balancing safety and efficacy is a major consideration for cancer treatments, especially when combining cancer immunotherapy with other treatment modalities such as …
OLD Cerqueira, MA Clavijo-Salomon… - Frontiers in …, 2020 - frontiersin.org
Immune evasion is an important cancer hallmark and the understanding of its mechanisms has generated successful therapeutic approaches. Induction of immunogenic cell death …